Search Count: 113
![]() |
A Broadly-Neutralizing Antibody Against Ebolavirus Glycoprotein That Can Potentiate The Breadth And Neutralization Potency Of Other Anti-Glycoprotein Antibodies
Organism: Oryctolagus cuniculus, Ebolavirus
Method: ELECTRON MICROSCOPY Release Date: 2025-11-05 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Structure Of The Measles Virus Fusion Protein Ectodomain E170G E455G With Mutated Furin Cleavage Site In The Pre-Fusion Conformation
Organism: Measles virus strain ichinose-b95a
Method: ELECTRON MICROSCOPY Release Date: 2025-10-22 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Pre-Fusion Herv-K Envelope Protein Trimer Ectodomain In Complex With Kenv-6 Fab
Organism: Homo sapiens, Enterobacteria phage t4, Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2025-07-30 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Organism: Mus musculus, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-07-30 Classification: VIRAL PROTEIN |
![]() |
Organism: Homo sapiens, Enterobacteria phage t4
Method: ELECTRON MICROSCOPY Release Date: 2025-07-30 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Sars-Cov-2 Nucleocapsid Dimerization Domain Bound To Fab-Np1E9 And Fab-Np3B4
Organism: Severe acute respiratory syndrome coronavirus 2, Mus sp.
Method: ELECTRON MICROSCOPY Release Date: 2025-05-14 Classification: VIRAL PROTEIN |
![]() |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2025-04-16 Classification: VIRAL PROTEIN/IMMUNE SYSTEM Ligands: NAG |
![]() |
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-12-25 Classification: IMMUNE SYSTEM |
![]() |
Structure Of A Sars-Cov-2 Spike S2 Subunit In A Pre-Fusion, Open Conformation
Organism: Severe acute respiratory syndrome coronavirus 2, Tequatrovirus t4, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2024-12-18 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Organism: Human betaherpesvirus 5
Method: ELECTRON MICROSCOPY Release Date: 2024-11-20 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Organism: Human betaherpesvirus 5
Method: ELECTRON MICROSCOPY Release Date: 2024-11-20 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Intracellular Cryo-Tomography Structure Of Ebov Nucleocapsid At 8.9 Angstrom
Organism: Ebola virus - mayinga, zaire, 1976, Zaire
Method: ELECTRON MICROSCOPY Release Date: 2024-10-02 Classification: VIRAL PROTEIN |
![]() |
In-Virion Structure Of Ebola Virus Nucleocapsid-Like Assemblies From Recombinant Virus-Like Particles (Nucleoprotein, Vp24,Vp35,Vp40)
Organism: Ebola virus - mayinga, zaire, 1976, Zaire
Method: ELECTRON MICROSCOPY Release Date: 2024-10-02 Classification: VIRAL PROTEIN/RNA |
![]() |
Organism: Sudan ebolavirus
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2023-09-27 Classification: VIRAL PROTEIN Ligands: SAL |
![]() |
Organism: Sudan ebolavirus
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2023-09-27 Classification: VIRAL PROTEIN Ligands: SAL |
![]() |
Structure Of Ebov Gp Lacking The Mucin-Like Domain With 2.1.1D5 Scfv And 6D6 Scfv Bound
Organism: Homo sapiens, Mus musculus, Ebola virus - mayinga, zaire, 1976
Method: ELECTRON MICROSCOPY Release Date: 2023-07-19 Classification: VIRAL PROTEIN/Immune System Ligands: NAG |
![]() |
Structure Of Ebov Gp Lacking The Mucin-Like Domain With 9.20.1A2 Fab And 6D6 Scfv Bound
Organism: Ebola virus - mayinga, zaire, 1976, Mus musculus, Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2023-07-19 Classification: VIRAL PROTEIN/Immune System Ligands: NAG |
![]() |
Organism: Homo sapiens, Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.57 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN Ligands: NAG |
![]() |
Organism: Sudan ebolavirus
Method: X-RAY DIFFRACTION Resolution:1.75 Å Release Date: 2023-06-21 Classification: VIRAL PROTEIN |
![]() |
Organism: Sudan ebolavirus
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2023-06-21 Classification: VIRAL PROTEIN |




















